IndiaTickerJenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.BSE · financial results · pdf
Source filing Company dossier
Jenburkt Pharmaceuticals
BSE:JENBURPH · ISIN INE354A01013
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jenburkt Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Registered Office AddressBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off DateBSE · corporate action · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Dividend UpdatesBSE · corporate action · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th May, 2026.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Audited Financial Results For The Quarter And Financial Year Ened On 31St March, 2026.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Taking On Record The Audited Financial Results For The Quarter And Financial Year Ended On 31St March, 2026 And To Consider Recommendation Of Dividend, If Any.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Disclosures Pursuant To SEBI Circular Dated 10Th August, 2021 :"Not A Large Corporate"BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December, 2025.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 03Rd February, 2026.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December, 2025. BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 28Th October, 2025.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2025.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2025.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 12Th August, 2025.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2025.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2025.BSE · financial results · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Proceedings Of The 40Th Annual General Meeting Of The Company Held On Today I.E. 18Th July, 2025.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 40Th Annual General Meeting Of The Company Schedule To Be Held On Friday, 18Th July, 2025 Through VC/OAVM.BSE · exchange filing · pdf
Source filing Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off DateBSE · corporate action · pdf
Source filing